Cheng, L.; Sun, B.; Xiong, Y.; Hu, L.; Gao, L.; Li, J.; Xie, H.; Chen, X.; Zhang, W.; Zhou, H.-H.
WGCNA-Based DNA Methylation Profiling Analysis on Allopurinol-Induced Severe Cutaneous Adverse Reactions: A DNA Methylation Signature for Predisposing Drug Hypersensitivity. J. Pers. Med. 2022, 12, 525.
https://doi.org/10.3390/jpm12040525
AMA Style
Cheng L, Sun B, Xiong Y, Hu L, Gao L, Li J, Xie H, Chen X, Zhang W, Zhou H-H.
WGCNA-Based DNA Methylation Profiling Analysis on Allopurinol-Induced Severe Cutaneous Adverse Reactions: A DNA Methylation Signature for Predisposing Drug Hypersensitivity. Journal of Personalized Medicine. 2022; 12(4):525.
https://doi.org/10.3390/jpm12040525
Chicago/Turabian Style
Cheng, Lin, Bao Sun, Yan Xiong, Lei Hu, Lichen Gao, Ji Li, Hongfu Xie, Xiaoping Chen, Wei Zhang, and Hong-Hao Zhou.
2022. "WGCNA-Based DNA Methylation Profiling Analysis on Allopurinol-Induced Severe Cutaneous Adverse Reactions: A DNA Methylation Signature for Predisposing Drug Hypersensitivity" Journal of Personalized Medicine 12, no. 4: 525.
https://doi.org/10.3390/jpm12040525
APA Style
Cheng, L., Sun, B., Xiong, Y., Hu, L., Gao, L., Li, J., Xie, H., Chen, X., Zhang, W., & Zhou, H.-H.
(2022). WGCNA-Based DNA Methylation Profiling Analysis on Allopurinol-Induced Severe Cutaneous Adverse Reactions: A DNA Methylation Signature for Predisposing Drug Hypersensitivity. Journal of Personalized Medicine, 12(4), 525.
https://doi.org/10.3390/jpm12040525